1- شمس آرا م.، سید علی قرشی (1385)، بیان پروتئین VP2 ویروس بیماری بورس عفونی و بررسی ایمنی زائی آن در مخمر. پژوهشگاه ملی مهندسی ژنتیک و زیست فناوری. تهران.
2- Arakawa T, Yu D.K, Chong J, Hough PC, Engen WH Landrige, (1998). A plant based cholera toxin B subunit-insulin
fusion protein protects against the development of autommune diabete. Nat. biotechnol., 16:934-938.
3- Azad A. A., Barrett, S. A. and Fahey, K. J. (1985). The characterization and molecular cloning of the double-stranded
dsRNA genome of an Australian strain of infectious bursal Disease Virus. Virology, 143: 35-44.
4- Becht, H., Müller, H. and Müller, H. K. (1988). Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J. Gen. Virol., 69: 631-640.
5- Bevan, M. , 1984. Binary vectors for plant transformation. Nucl. Acids. Res. 12: 8711-8721.
6- Dybing, J. K. and Jackwood, D. J. (1997). Expression of MD infectious bursal disease viral proteins in baculovirus. Avian
Dis., 41: 617-626.
7- Fahey, K. J., Erny, K. and Crooks, J. (1989). A conformational immunogen on VP2 of infectious bursal disease virus that
induces virus-neutralizing antibodies that passively protect chickens. J. Gen. Virol., 70: 1473-1481.
8- Fieler U , Artsaenko O , Conrad U. (1997). Optimisation of Scfv antibody production in transgenic plant. Immunology, 3:
205-216.
9- Fischer R. and Schilberg S. (2004). Molecular Farming:plant-made pharmaceuticals and technical proteins. WILEYVCH Verlag GmbH & Co.KGaA.
10- Fischer R., Stoger E., Schillberg S., Christou P. and Twyman R. (2004). Plant based production of Biopharmaceuticals.
Current Opinion in plant Biology, 7:152-158.
11- Gidding G., Allison G., Brooks D, Carter A. (2000). Transgenic Plants as Factories for Biopharmaceuticals. Nat
Biotechnol., 18:1151-1155.
12- Hashemi Sohi H., Jourabchi E., Khodabandeh M. (2005). Transient expression of human growth hormone in potato
(Solanum tuberosum), tobacco (Nicotiana tabacum) and lettuce (Lactuca sativa) leaves by Agroinfiltration. Iranian Journal of Biotechnology, l2(3): 109-114.
13- Jianxiang Wu, Lian Yu, Long Li, Jinqiang Hu, Jiyong Zhou and Xueping Zhou, (2007). Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnology Journal, 5: 570–578
14- Julian K.-C. M., Pascal M. W. Drake and P. Christou, (2003). The production of recombinant biopharmaceuticals in
plants. Nature Review Genetic, 4: 790-796.
15- Kapila J, De Rycke R, Van Montague M, Angenon G., (1997). An Agrobacterium –mediated transient gene expression
system for intact leaves. Plant Sci, 122 :101-108.
16- Lameli UK, (1970). Cleavage of structural protein in during the assembly of the head of bacteriophage T4. Nature 227:680- 685.
17- Macreadie, I. G., Vaughan, P. R., Chapman, A. J., Mckern N. M., Jagadish, M. N., Heine, H. G., Ward, C. W., Fahey, K.
J. and Azad, A. A., (1990). Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. accine, 8: 549-552.
18- Martinez-Torrecuadrada, J. L., Saubi N., Pages-Mante A., Caston J. R., Espuna, E. and Casal, J. I.,(2003). Structuredependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine, 21: 3342-3350.
19- Miele L., (1997). Plants as Bioreactor for biopharmaceuticals. Trends in Biotech., 15:45-50.
20- Pitcovski. J., Gutter, B., Gallila, G., Goldway, M., Perelman, B., Gross, G., Krispel, S., Barbakov, M. and Michael, A., (2003). Development and large-scale use of recombinant VP2 vaccinefor the prevention of infectious bursal disease of chickens. Vaccine, 21: 4736-4743.
21- Raskin I., Ribnicky D. M., Komarnytsky S., IIic N., Poulev A., Borisjuk N., Brinker A., Moreno D. A., Ripoll C., Yakoby N., O΄Neal J. M., Cornwell T., Pastor I. And Fridlender B., (2002). Plants and human health in the twenty-first century. Trends in biotechnology, 20(12):522-531.
22- Sambrook J., Fritsch F. F., Maniatis T., (1989). Molecular cloning: A laboratory manual. Second edition, Cold spring
Hrrbor laboratory press.
23- Shamsara M., Ghorashi SA, Ahmadian G., (2006). Cloning and nucleotide analysis of the VP2 gene of a very virulent
infectious bursal disease virus isolate from Iran. Acta virol, 50(4):229-234.
24- Spies U., Müller H. and Becht H., (1987). Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res., 8: 127-140.
25- Streatfield S. J., Joseph M. Jilka, Elizabeth E. Hood, Debra D. Turner, Michele R. Bailey, Jocelyne M. Mayor a, Susan L. Woodard a, Katherine K. Beifuss a, Michael E. Horn a, Donna E. Delaney a, Ian R. Tizard b, Howard J. A., (2001). Plant-based vaccines: unique advantages. Vaccine 19: 2742-2748.
26- Ture, O., Tsai, H. J. and Saif, Y. M., (1993). Studies on antigenic relatedness of classic and variant strains of infectious
bursal disease viruses. Avian Dis., 37: 647-654.
27- Waugh D. S., (2005). Making the most of affinity tags. Trends in biotechnology, 23(6) 316-320.
28- Wroblewski T, Tomczak A, and Richard Michelmore, (2005). Optimization of Agrobacterium-mediated transient
assays of gene expression in lettuce, tomato and Arabidopsis. Plant Biotechnology Journal, 3(2):259-275.
29- Wu H, Singh NK, Locy RD, Scissum-Gunn K, Giambrone, (2004). Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana. Biotechnology letters, 26(10):787-792.
)
